| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.15 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |